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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanBackground: Fever of unknown origin (FUO) was first described in 1961 as fever >38.3C for at
least 3 weeks with no apparent source after 1 week of investigations in the hospital. Infectious
disease comprises the majority of cases (40e60%). There is no related research on FUO in chil-
dren in Taiwan. The aim of this study is to determine the etiologies of FUO in children in
Taiwan and to evaluate the relationship between the diagnosis and patient’s demography
and laboratory data.
Methods: Children under 18 years old with fever >38.3C for >2 weeks without apparent
source after preliminary investigations at Taipei Veterans General Hospital during 2002
e2012 were included. Fever duration, symptoms and signs, laboratory examinations, and final
diagnosis were recorded. The distribution of etiologies and age, fever duration, laboratory
examinations, and associated symptoms and signs were analyzed.
Results: A total of 126 children were enrolled; 60 were girls and 66 were boys. The mean age
was 6.7 years old. Infection accounted for 27.0% of cases, followed by undiagnosed cases
(23.8%), miscellaneous etiologies (19.8%), malignancies (16.6%), and autoimmune disorders
(12.7%). Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were the most commonly found
pathogens for infectious disease, and Kawasaki disease (KD) was the top cause of miscella-
neous diagnosis.of Pediatrics, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan,
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j.jmii.2015.01.001Conclusions: Infectious disease remains the most common etiology. Careful history taking and
physical examination are most crucial for making the diagnosis. Conservative treatment may
be enough for most children with FUO, except for those suffering from malignancies.
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Fever of unknown origin (FUO) is defined as a well-
documented fever with a body temperature >38.3C
(101F) for at least 3 weeks without any apparent source
after 1 week of investigation in a hospital.1 It is generally
accepted that a fever for >1 week in a child warrants
further investigation, since most viral febrile episodes
subside within 1 week. A fever that continues beyond 5e7
days, or one that occurs on and off, usually prompts parents
to seek medical advice. For this reason, the inclusion
criteria in recent systematic reviews on pediatric FUO are
pediatric patients with a fever persisting for 1e2 weeks
with negative preliminary investigations, or without a
diagnosis after three outpatient visits.2 These criteria are
more acceptable to most primary care physicians.
The incidence of FUO ranges from 0.5% to 3% in all hos-
pitalized children,3 with the proportion of those diagnosed
varying from study to study. Overall, an infectious illness is
the most common cause of FUO in children (40e60%), fol-
lowed by autoimmune disease (10e20%), malignancies
(5e10%), and miscellaneous conditions (5e10%),2,5 with
10e20% of cases being undiagnosed.2,4 The number of un-
diagnosed cases is increasing, which may be due to im-
provements in diagnostic techniques so that illnesses which
were previously thought to be among the causes are now
diagnosed earlier before the onset of the FUO.6
The diagnosis of a prolonged fever in children requires
extensive history taking, thorough physical examination,
and a series of complementary laboratory examinations. A
delay in ordering appropriate surveys and a failure to
interpret the findings may lead to the actual underlying
cause being missed, potentially resulting in a life-
threatening condition. As there are currently no published
studies describing the causes and distribution of FUO in
children in Taiwan, the present study aimed to determine
the etiologies of FUO among children in Taiwan, and
compare the findings to previous research to elucidate the
indicators of life-threatening conditions.
Materials and methods
This retrospective study analyzed the medical records of
children aged <18 years old with a fever of >38.3C for
longer than 2 weeks without an apparent source after
preliminary investigations at Taipei Veterans General Hos-
pital from January 2000 to December 2012. The Institu-
tional Review Board of Taipei Veterans General Hospital
approved the study protocol (VGHIRB No. 2013-05-026B).
Children with a definitive diagnosis at the time of
referral, any previously known congenital or acquired
immunosuppressive deficiency, or malignancies wereho C-Y, et al., Clinical analysis o
, Journal of Microbiology, Imexcluded. Data on age, sex, duration of fever, history of
illness, physical examination findings, basic laboratory in-
vestigations such as white blood cell (WBC), differential,
and platelet count, levels of hemoglobin, C-reactive protein
(CRP), and ferritin, urinalysis, and urine and blood cultures
were obtained. Further serum examinations including
complement component 3 (C3), complement component 4
(C4), double-stranded deoxyribonucleic acid (dsDNA),
antinuclear antibody (ANA), and virology studies were
retrieved based on individual situations. Imaging studies
such as chest X-ray, abdominal sonography, and computed
tomography, and invasive procedures such as lumbar
puncture and bone marrow aspiration were also recorded.
We made the diagnosis of cytomegalovirus (CMV),
Epstein-Barr virus (EBV), and mycoplasma infection based
on the clinical presentations using positive viral serologic
tests; that is, positive CMV immunoglobulin (Ig) M antibody
(Ab) and/or positive urine CMV culture, positive EBV-viral
capsid antigen (EBV-VCA) IgM Ab with a four-fold increase of
IgG titer in paired sera, and positive mycoplasma IgM Ab.
Children presenting with injected tonsils, productive cough,
and rhinorrhea were grouped into upper respiratory infec-
tion. The definition of central nervous system infection was
based on clinical manifestations such as headache, neck
stiffness, and fever, with cerebrospinal fluid (CSF) pleocy-
tosis and low CSF sugar level. Urinary tract infection was
diagnosed using positive urine cultures. Summer fever and
central fever were diagnosed using clinical presentation
and exclusion. Patients who had prolonged fever especially
during midnight or early morning, along with some institu-
tional symptoms such as anorexia, sleeplessness, and
gastrointestinal illness, which resolved while staying in an
air-conditioned room, were diagnosed as having summer
fever. Central fever indicated the absence of a documented
infection in the febrile patients with neurologic disease,
such as brain tumor or traumatic injury. It resulted from the
dysfunction of the regulatory center at the hypothalamus.
The definitive diagnosis, if any, and prognosis were
documented according to the discharge notes and outpa-
tient department records. After reviewing all of these data,
the patients were categorized as having fever due to in-
fectious disease, autoimmune disease, malignancy, or a
miscellaneous condition. If the cause of fever was not
identified, the case was classified as being undiagnosed.
Statistical analysis was performed using the Chi-square
test (goodness-of-fit) with SPSS software (SPSS Inc., Chi-
cago, IL, USA).
Results
One hundred and twenty-six children suffering from a
prolonged fever of >14 days without an initial definitef fever of unknown origin in children: A 10-year experience in a
munology and Infection (2015), http://dx.doi.org/10.1016/
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(52%) boys, with a mean age of 6.7 years (range, 1 month to
18 years). Thirty-four (27%) children were aged 1 month to
2 years, 30 (24%) were aged 3e6 years, 17 (13%) were aged
7e10 years, and 45 (36%) were >10 years old.
Ninety-six cases had a definitive diagnosis, including 34
(27%) cases with infectious diseases, 25 (19.8%) with
miscellaneous etiologies, 21 (16.6%) with malignancies, and
16 (12.7%) with autoimmune diseases (Table 1). Thirty
(23.8%) cases remained undiagnosed.
Among the patients with infectious diseases, most
(35%) suffered from upper respiratory infections. Six
(17.6%) and five (14.7%) children with infectious diseases
had systemic CMV and EBV infections, respectively. Five
cases (14.7%) had urinary tract infections, with Escher-
ichia coli, Enterococcus species, Klebsiella species, and
Pseudomonas aeruginosa as the pathogens. The majority
of patients with infectious diseases recovered after sup-
portive management or antibiotic treatment and had
relatively fair outcomes.
Twenty-five patients were diagnosed as having miscel-
laneous disorders, including 15 patients with Kawasaki
disease (KD), two patients with central fever, one patient
with summer fever, one patient with myelodysplastic syn-
drome, one patient with aplastic anemia, three patients
with hemophagocytic lymphohistiocytosis (HLH), and two
patients with histiocytosis.Table 1 Age distribution and final diagnosis of children with fe
Diagnosis n % 1 mo
Infectious disease 34 27 9 (7.
CMV infection 6 4.8 d
EBV infection 5 4.0 1
Mycoplasma infection 2 1.6 1
Upper respiratory infection 12 9.5 1
Urinary tract infection 5 4.0 4
CNS infection 3 2.3 2
Lymphadenitis 1 0.8
Autoimmune disease 16 12.7 d
SLE 13 10.3 d
JRA 2 1.6 d
Autoimmune cholangitis 1 0.8 d
Malignancies 21 16.6 1 (0.
ALL 18 14.3 1
Lymphoma 3 2.3 d
Miscellaneous 25 19.8 17 (1
Kawasaki disease 15 11.9 13
Central fever 2 1.6 1
Summer fever 1 0.8 1
MDS 1 0.8 d
AA 1 0.8 d
HLH 3 2.3 d
Histiocytosis 2 1.6 2
Undiagnosed 30 23.8 6 (4.
Total 126 100 33 (2
*p < 0.01.
AA Z aplastic anemia; ALL Z acute lymphoid leukemia; CMV Z cytom
virus; HLH Z hemophagocytic lymphohistiocytosis; JRA Z juven
n Z number of patients having the specific diagnosis; SLE Z systemi
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j.jmii.2015.01.001KD accounted for more than half of the cases in this group
(60%), with all of the patients being younger than 6 years
old. Fourteen of them had received aspirin and intravenous
Ig treatment. Those children with HLH and histiocytosis had
relatively unfavorable outcomes compared to the other
etiologies. Two of the three patients with HLH and one of the
two patients with histiocytosis died despite intensive
chemotherapy or bone marrow transplant. The patient with
myelodysplastic syndrome also died after steroid pulse
therapy and bone marrow transplant.
Of the 16 patients with autoimmune disorders, more
than half (13 cases) had systemic lupus erythematous, all of
whom were girls >10 years of age. Another two patients
had juvenile rheumatoid arthritis, and the remaining pa-
tient had autoimmune cholangitis. After receiving methyl-
prednisolone pulse therapy or immunomodulators, all of
them were discharged under regular outpatient clinic
follow up.
With regards to the children with malignancies, 18 pa-
tients had acute lymphoid leukemia (ALL) and three pa-
tients had lymphoma. Most patients smoothly completed a
series of chemotherapy and were under regular outpatient
follow up. However, two patients with ALL and two patients
with lymphoma died due to sepsis while receiving
chemotherapy.
The age distribution for the different etiologies is sum-
marized in Table 1. In the autoimmune group, significantlyver of unknown origin (FUO)
e2 y (%) 3e6 y (%) 7e10 y (%) >10 y (%)
1) 8 (6.4) 5 (4.0) 12 (9.5)
3 d 3
2 d 2
d 1 d
3 3 5
d 1 d
d d 1
1
d 2 (1.6) 14 (11.1)*
d d 13
d 2 d
d d 1
8) 8 (6.3) 3 (2.4) 9 (7.1)
7 2 8
1 1 1
3.4)* 5 (4.0) d 3 (2.4)
2 d d
1 d d
d d d
d d 1
1 d d
1 d 2
d d d
8) 9 (7.1) 9 (7.1) 6 (4.8)
6.2) 30 (23.8) 19 (15.0) 44 (35.0)
egalovirus; CNSZ central nervous system; EBV Z EpsteineBarr
ile rheumatoid arthritis; MDS Z myelodysplastic syndromes;
c lupus erythematosus.
f fever of unknown origin in children: A 10-year experience in a
munology and Infection (2015), http://dx.doi.org/10.1016/
Table 2 The relationship between duration of fever and
final diagnosis
Cause 14e30 d (%) 31e60 d (%) >60 d (%)
Infectious disease 26 (20.63)* 7 (5.56) 1 (0.80)
Autoimmune disease 9 (7.14) 5 (3.97) 2 (1.59)
Malignancies 13 (10.32)** 6 (4.76) 2 (1.59)
Miscellaneous 20 (15.87)* 4 (3.17) 1 (0.80)
Undiagnosed 20 (15.87)* 8 (6.45) 2 (1.59)
Total 88 (69.84) 30 (23.81) 8 (6.35)
*p < 0.01, **p Z 0.005.
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+ MODELmore children were >10 years of age (87.5%) compared to
the other age groups (p < 0.01). In this group, 76.9% suf-
fered from systemic erythematous lupus. There were
significantly more infants (68.0%) in the miscellaneous
group (p < 0.01), 76.4% of whom were diagnosed with KD.
Regarding the relationship between duration and causes
of FUO (Table 2), 88 patients (69.8%) had FUO within 30
days, and eight patients (6.35%) had FUO for >2 months.
Twenty six of 34 (76.4%) patients in the infectious disease
group, 13 of 21 (61.9%) patients with malignancies, 20 of 25
(80.0%) patients in the miscellaneous group, and 20 of 30
(66.6%) patients in the undiagnosed group had a fever
within 30 days, which were significantly higher than in
those with a fever for >60 days (p < 0.001, p Z 0.005,
p < 0.001, and p < 0.001, respectively).
In terms of the associated clinical findings (Table 3), the
patients with infectious diseases tended to have poor appe-
tite and activity. Symptoms of upper respiratory infectionsTable 3 The association of clinical findings with causes of feve
Associated clinical findings Infections disease
(n Z 34)
Autoimmun
(n Z 16)
Poor appetite and activity 11 (32.4%) 6 (37.5%)
URI symptoms/signs 15 (44.1%) 3 (18.8%)
BW loss 3 (8.8%) 4 (25.0%)
Lymphadenopathy 6 (17.6%) 2 (12.5%)
Arthralgia/myalgia 3 (8.8%) 10 (62.5%)
Skin rash 7 (20.6%) 5 (31.3%)
BW Z body weight; n Z number of patients having the specific diag
Table 4 Distribution of laboratory data among each cause of f
Causes of FUO WBC (109/mm3) (%) Diffe
<5 5e10 10e20 >20 PMN
Infections
disease
5 (14.7) 15 (44.1) 13 (38.2) 1 (3.0) 21 (61.
Autoimmune
disease
9 (56.2) 5 (31.2) 1 (6.3) 1 (6.3) 16 (100
Malignancies 10 (47.6) 5 (23.8) 1 (4.8) 5 (23.8)* 7 (33.
Miscellaneous 2 (8.0) 10 (40.0) 7 (28.0) 6 (24.0)* 22 (88.
Undiagnosed 5 (16.7) 13 (43.3) 10 (33.3) 2 (6.7) 25 (83.
*p < 0.01.
CRPZ C-reactive protein; Hb Z hemoglobin; L Z lymphocyte predo
ulocyte predominant; WBC Z white blood cell.
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j.jmii.2015.01.001were also frequently found in this group. Body weight loss
was more commonly seen among the patients suffering from
autoimmune disorders, followed by thosewithmalignancies.
Thepatients in themiscellaneous groupwereassociatedwith
a higher frequency of skin rashes, whereas the patients with
autoimmune diseases were characterized by arthralgia and
myalgia. However, none of the above symptoms or signs
showed a statistically significant relationship with the spe-
cific cause.
The correlations of laboratory data and etiologies are
shown in Table 4. The WBC count ranged between 5  109/
mm3 and 20  109/mm3 in most cases. A higher WBC count
(>20  109/mm3) was found more frequently among the
malignancy (23.8%) and miscellaneous (24.0%) groups
(p < 0.01), which was mainly due to ALL and KD. The pre-
dominance of polymorphonuclear granulocyte was signifi-
cantly more common (88%) in the miscellaneous group,
autoimmune disease group (100%), and undiagnosed group
(83.3%; p< 0.01). Elevated CRP levels (>1mg/dL) were seen
more commonly in the infectious disease and miscellaneous
groups (p< 0.01). The hemoglobin level fell below 12 g/dL in
the autoimmune disease, malignancy, and miscellaneous
groups (p < 0.01). The platelet count was found to be
significantly lower in the patients with autoimmune disor-
ders (56.3%) and malignancies (80.9%), whereas the patients
with KD tended to have thrombocytosis.
With regards to prognosis, nine of 126 cases (7.14%)
died. Of these cases, two had ALL, two had lymphoma, two
had HLH, one had myelodysplastic syndrome, one had his-
tiocytosis with bone marrow involvement, and one had CMV
infection. None of the patients who remained undiagnosed
had unfavorable outcomes in this study.r of unknown origin (FUO)
e disease Malignancies
(n Z 21)
Miscellaneous
(n Z 25)
Undiagnosed
(n Z 30)
4 (19.0%) 4 (6.0%) 4 (13.3%)
6 (28.6%) 14 (56.0%) 8 (26.7%)
3 (14.3%) 0 (0%) 2 (6.7%)
5 (23.8%) 5 (20.0%) 3 (10.0%)
7 (33.3%) 2 (8.0%) 1 (3.3%)
0 (0%) 14 (56.0%) 2 (6.7%)
nosis; URI Z upper respiratory infection.
ever of unknown origin (FUO)
rential count CRP (mg/dL) Hb (g/dL) PLT (103/mm3)
L >1 <12 <150 >450
8) 13 (38.2) 18 (53.0)* 22 (64.7) d 4 (11.7)
.0)* d 6 (37.5) 14 (87.5)* 9 (56.3)* 1 (3.8)
3) 14 (66.7) 9 (42.8) 20 (95.2)* 17 (80.9)* d
0)* 3 (12.0) 19 (76.0)* 24 (96.0)* 5 (20) 3 (12)
3)* 5 (16.7) 12 (40) 17 (56.7) 4 (13) 5 (16.7)
minant; PLT Z platelet count; PMN Z polymorphonuclear gran-
f fever of unknown origin in children: A 10-year experience in a
munology and Infection (2015), http://dx.doi.org/10.1016/
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The present study showed that FUO in children is still mainly
caused by infectious diseases. Of these infectious diseases,
upper respiratory infections were the leading cause, fol-
lowed by systemic viral infections, with CMV and EBV as the
most common pathogens. Previous reviews have also indi-
cated similar results,7,8 and previous studies have found
that the incidence of infections decreases gradually as the
patients get older.9,10 However, there were no significant
differences among the age groups in the present study.
In the miscellaneous group, KD was the cause of >50% of
cases, a phenomenon rarely reported in previous studies.
This may be the result of better diagnostic methodologies
in the current study than in earlier studies, in which cases
of KD may have been unrecognized. Furthermore, the
annual incidence of KD in Taiwan is the third highest in the
world (69/100,000 for children <5 years of age).11 There-
fore, when facing children younger than 5 years of age with
a prolonged fever in Taiwan, KD should be kept in mind as
one of the most likely diagnoses.
In the current study, three patients were diagnosed with
HLH, two of whom died despite intensive chemotherapy
and intravenous Ig treatment. The mortality rate was
significantly higher than for other diseases (p < 0.01). A
previous study reported that patients with HLH may not
have a typical initial presentation, and that fever persisted
for a median of 19 days before the diagnosis was made.12
This may explain why a diagnosis is often delayed. Over-
all, the reported mortality rate of HLH is around 50%,12,13
and prompt recognition of the disease is essential to
allow for the initiation of appropriate therapy.
Malignancies have been reported in only a small per-
centage of cases of FUO in most studies (1.5e6%).2,7e9,14
This is in contrast to adults with FUO, in which the inci-
dence of neoplasms can reach up to 7e16%.15,16 However,
in our study, ALL and lymphoma accounted for 16% of cases,
which is similar to previous adult studies. Most of our pa-
tients with ALL and lymphoma underwent scheduled
chemotherapy without complications.
With respect to the correlation between fever duration
and etiology (Table 2), approximately 70% of the patients
had a fever within 30 days, with infectious disease as the
leading cause, and only 6.3% had a fever lasting >60 days.
Although in our study there was no significant correlation
between clinical presentation and etiology, many studies
have stressed the importance of careful survey of symp-
toms/signs as significant factors in determining further
management.5,17
Aside from clinical presentation, laboratory data may
provide essential clues for a differential diagnosis. Elevated
WBC and CRP are regarded as indicators for infection or
inflammation.18 Our results demonstrated a higher WBC
count and CRP level among those with infectious diseases,
and a predominance of polymorphonuclear granulocytes
and a lower hemoglobin level in those with autoimmune
disorders and malignancies. Furthermore, a high WBC count
(>20  109/mm3) was noted in the patients with malig-
nancies and KD. Platelet count was also addressed in our
study because it is regarded as an acute phase reactant,
and it was found to be significantly lower in the patientsPlease cite this article in press as: Cho C-Y, et al., Clinical analysis o
northern Taiwan medical center, Journal of Microbiology, Im
j.jmii.2015.01.001with autoimmune disorders and malignancies. In other
words, thrombocytopenia may raise the awareness of the
illness in these categories.
In addition to serum examinations, imaging can be
helpful for diagnosis. Chest X-ray is usually the only radio-
logical survey included in the initial work-up.19 Computed
tomography is also a helpful diagnostic tool in children with
localized diseases, however, it has a relatively lower
yield.20 Positron emission tomography with F-fluorodeox-
yglucose plays a role in the distinction between scarring or
fibrosis and active tumors.21e23 In the current study, none
of the patients achieved a final diagnosis via nuclear med-
icine imaging or positron emission tomography studies,
which is similar to previous studies.24
For prognosis, in previous studies patients have been
observed clinically for progression of illness if there were
no positive findings.25 More than 80% of reported cases have
not had a serious illness after a median follow up of 3.5
years.26e28
There are some potential limitations to our study. First,
the definition of FUO varies widely in duration from study to
study. Second, the database was retrieved from only one
tertiary medical center with more complicated cases, and
the incidence of severe infections, malignancies, and un-
diagnosed cases may be higher in this hospital setting.
Consequently, the results may not be able to illustrate the
current epidemiology of FUO in Taiwan. In addition, some
of the enrolled cases are lacking definite cultures or mo-
lecular laboratory data. In addition, diseases such as KD
have not been identified in earlier studies, and the preva-
lence of KD varies in different regions of the world. Newly-
developed diagnostic technologies can also alter the dis-
tribution of etiologies.
In conclusion, a detailed history taking and careful
physical examination are most crucial for children with
FUO. Only when indicated by these investigations can lab-
oratory data, imaging studies, or even invasive procedures
augment the efficiency of making the diagnosis, especially
when considering cost-effectiveness. Prognosis is deter-
mined primarily by the underlying disease, and to a lesser
extent, by prompt diagnosis. The outcome is the worst for
patients with neoplasms.
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